Worcester police arrest man accused of shooting at party that left woman wounded
Published Thu, 20 Feb 2025 11:48:23 GMT
Federal team sent to ‘assess’ migrant situation to visit Boston Tuesday, Wednesday
Published Thu, 20 Feb 2025 11:48:23 GMT
Chicago Bears secondary could get some help this week — and it won’t have to defend Justin Jefferson
Published Thu, 20 Feb 2025 11:48:23 GMT
Former MLB All-Star Steve Garvey announces run for U.S. Senate in California
Published Thu, 20 Feb 2025 11:48:23 GMT
Newsom signs bill to ban hidden fees in California
Published Thu, 20 Feb 2025 11:48:23 GMT
The future of electric vehicles looms over negotiations in the US autoworkers strike
Published Thu, 20 Feb 2025 11:48:23 GMT
Finnish president says undersea gas and telecom cables damaged by ‘external activity’
Published Thu, 20 Feb 2025 11:48:23 GMT
The Supreme Court rejects an appeal from former coal company CEO Don Blankenship
Published Thu, 20 Feb 2025 11:48:23 GMT
Toronto’s alcohol in parks pilot ends with few official complaints. What’s next?
Published Thu, 20 Feb 2025 11:48:23 GMT
Hurricane Lidia takes aim at Mexico’s Puerto Vallarta resort with strengthening winds
Published Thu, 20 Feb 2025 11:48:23 GMT
Latest news
- RPM International, Acuity Brands rise; Cal-Maine, Helen of Troy fall, Wednesday, 10/4/2023
- Kenyan opposition lawmakers say the Haiti peacekeeping mission must be approved by parliament
- Tennis player apologizes for hitting a chair umpire with ball in Shanghai Masters qualifying
- Jannik Sinner wins China Open. Iga Swiatek advances to quarterfinals
- Pakistani army says 2 people were killed when a Taliban guard opened fire at a border crossing
- Meet this year’s MacArthur ‘genius grant’ recipients, including a hula master and the poet laureate
- A man charged with voter fraud in Florida blames rivalry between Trump and DeSantis supporters
- Rudy Giuliani: ‘I have never had an alcohol problem’
- Scalise and Jordan launch bids for House speaker after McCarthy ouster
- Moderna’s flu-Covid combo vaccine elicits ‘strong’ immune response in Phase 1/2 study, company says